A Phase I Study to Assess the Safety and Tolerability of BL0006 for Patients With Advanced Solid Tumours

NCT06247657 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: BL0006

Sponsor

Shanghai Best-Link Bioscience, LLC